BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes
BRADYCARE
Advanced Bradycardia Device Feature Utilization and Clinical Outcomes
1 other identifier
observational
3,389
0 countries
N/A
Brief Summary
Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include automated capture, automated sensing, patient alert functions, algorithms minimizing ventricular pacing, automatic mode switching in response to atrial tachyarrhythmia, rate responsive pacing, advanced diagnostic features, remote monitoring and radiofrequency (RF) technology. However, little information is available on how these new features are being utilized by physicians in the real world and how these features impact patient outcomes. This observational study will gather data on the patients' presenting clinical status, indication for device implantation, utilization of advanced device features, device therapy choices, clinical management and outcomes in a general pacemaker population. The primary aim of the study is to evaluate the usage of advanced features and diagnostics in patients with St. Jude Medical pacemakers. The secondary aim of the study is to learn more about the progressive clinical outcomes in the general pacemaker patient population. The tertiary aim of the study is to evaluate the correlation between the usage of advanced features in pacemaker patients and the patient's clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2010
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 2, 2010
CompletedFirst Posted
Study publicly available on registry
February 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedResults Posted
Study results publicly available
October 14, 2020
CompletedOctober 14, 2020
September 1, 2020
2.6 years
February 2, 2010
October 7, 2019
September 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complication Rate at 1-year Post-implant
Complication rate and 95% confidence interval at 1-year post-implant
12 months
Eligibility Criteria
Patients indicated for standard Pacemaker indications
You may qualify if:
- Patient has a current indication for a single-chamber (SR) or dual-chamber (DR) pacemaker or CRT-P device.
- Patient is implanted with an SJM Accent™ SR/DR, Accent™ SR/DR RF, Anthem™ CRT-P, Anthem™ CRT-P RF, or newer SJM pacemaker device.
- Patient is geographically stable and willing to comply with the required follow-up schedule.
- Patient is not pregnant or planning to become pregnant.
- Patient is \>18 years of age.
You may not qualify if:
- Patient's life expectancy is less than 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Results Point of Contact
- Title
- Grant Kim
- Organization
- Abbott (Previously St Jude Medical)
Study Officials
- STUDY DIRECTOR
Grant Kim
Abbott (previously St. Jude Medical)
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2010
First Posted
February 4, 2010
Study Start
February 1, 2010
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
October 14, 2020
Results First Posted
October 14, 2020
Record last verified: 2020-09